Growth Metrics

Protalix BioTherapeutics (PLX) Cash from Operations Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 37.40%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 20.11%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 16.64%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -7.60%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 34.32%
10 Protalix BioTherapeutics 164.49 Mn 153.70 Mn 29.62 Mn 110.64%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 110.64%
Dec 31, 2025 40.57%
Sep 30, 2025 25.98%
Jun 30, 2025 10.73%
Mar 31, 2025 4.62%
Dec 31, 2024 40.69%
Sep 30, 2024 61.13%
Jun 30, 2024 -36.69%
Mar 31, 2024 34.37%
Dec 31, 2023 35.29%
Sep 30, 2023 -24.10%
Jun 30, 2023 38.12%
Mar 31, 2023 25.04%
Dec 31, 2022 10.87%
Sep 30, 2022 -41.85%
Jun 30, 2022 -12.47%
Mar 31, 2022 7.12%
Dec 31, 2021 -8.31%
Sep 30, 2021 -28.82%
Jun 30, 2021 41.25%
Mar 31, 2021 -1.47%
Dec 31, 2020 -34.38%
Sep 30, 2020 30.32%
Jun 30, 2020 2.67%
Mar 31, 2020 5.92%
Dec 31, 2019 20.54%
Sep 30, 2019 2.05%
Jun 30, 2019 24.58%
Mar 31, 2019 7.75%
Dec 31, 2018 9.17%
Sep 30, 2018 50.03%
Jun 30, 2018 -22.30%
Mar 31, 2018 -15.14%
Mar 31, 2017 -0.82%
Dec 31, 2016 -80.08%
Sep 30, 2016 25.25%
Jun 30, 2016 -14.11%
Mar 31, 2016 1.12%
Dec 31, 2015 -70.24%
Sep 30, 2015 -7.25%
Jun 30, 2015 -32.61%
Mar 31, 2015 0.61%
Mar 31, 2014 -27.88%
Dec 31, 2013 30.81%
Sep 30, 2013 5.32%